These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4715992)

  • 21. In vivo release of endogenously synthesized catecholamines from the cat brain evoked by electrical stimulation and by d-amphetamine.
    Chiueh CC; Moore KE
    J Neurochem; 1974 Jul; 23(1):159-68. PubMed ID: 4852387
    [No Abstract]   [Full Text] [Related]  

  • 22. Regional effects of L-dihydroxyphenylalanine (L-dopa) on norepinephrine metabolism in rat brain.
    Romero JA; Chalmers JP; Cottman K; Lytle LD; Wurtman RJ
    J Pharmacol Exp Ther; 1972 Feb; 180(2):277-85. PubMed ID: 5010674
    [No Abstract]   [Full Text] [Related]  

  • 23. L-Dopa-induced release of cerebral monoamines.
    Ng KY; Chase TN; Colburn RW; Kopin IJ
    Science; 1970 Oct; 170(3953):76-7. PubMed ID: 5452893
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transmitter-dependent changes of equilibrium characteristics of catecholamine synaptosomes in sucrose density gradients.
    Pycock C; Jonsson G
    Med Biol; 1974 Aug; 52(4):260-8. PubMed ID: 4371596
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of L-dopa on the hypothalamic, pineal and striatal monoamines and on the sexual behaviour of the rat.
    Hyyppä M; Lehtinen P; Rinne UK
    Brain Res; 1971 Jul; 30(2):265-72. PubMed ID: 5315473
    [No Abstract]   [Full Text] [Related]  

  • 26. Regional release of aromatic amines from tissues of the rat brain in vitro.
    Baldessarini RJ; Vogt M
    J Neurochem; 1972 Mar; 19(3):755-61. PubMed ID: 4555500
    [No Abstract]   [Full Text] [Related]  

  • 27. Brain DOPA-5-HTP decarboxylase activity after the chronic administration of L-dopa or 5-hydroxy-L-tryptophan in normal and lesioned cats.
    Roberge AG; Poirier LJ
    Brain Res; 1974 Aug; 76(3):401-12. PubMed ID: 4546739
    [No Abstract]   [Full Text] [Related]  

  • 28. Failure of 6-hydroxynoradrenaline to produce degeneration of catecholamine neurons.
    Sachs C
    Eur J Pharmacol; 1972 Nov; 20(2):149-55. PubMed ID: 4651204
    [No Abstract]   [Full Text] [Related]  

  • 29. L-dopa in Parkinsonism. A possible mechanism of action.
    Ng LK; Chase TN; Colburn RW; Kopin IJ
    Neurology; 1972 Jul; 22(7):688-96. PubMed ID: 4673250
    [No Abstract]   [Full Text] [Related]  

  • 30. A comparison of the capacities of isomers of amphetamine, deoxypipradrol and methylphenidate to inhibit the uptake of tritiated catecholamines into rat cerebral cortex slices, synaptosomal preparations of rat cerebral cortex, hypothalamus and striatum and into adrenergic nerves of rabbit aorta.
    Ferris RM; Tang FL; Maxwell RA
    J Pharmacol Exp Ther; 1972 Jun; 181(3):407-16. PubMed ID: 5033010
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of tyrosine hydroxylase inhibition on the action of 6-hydroxydopamine.
    Jonsson G; Sachs C
    Res Commun Chem Pathol Pharmacol; 1973 Mar; 5(2):287-96. PubMed ID: 4144667
    [No Abstract]   [Full Text] [Related]  

  • 32. Distribution and metabolism of norepinephrine after its administration into the cerebroventricular system of the cat.
    Carr LA; Moore KE
    Biochem Pharmacol; 1969 Aug; 18(8):1907-18. PubMed ID: 4390276
    [No Abstract]   [Full Text] [Related]  

  • 33. Noradrenaline nerve terminals in the cerebral cortex: effects on noradrenaline uptake and storage following axonal lesion with 6-hydroxydopamine.
    Lidbrink P; Jonsson G
    J Neurochem; 1974 May; 22(5):617-26. PubMed ID: 4152079
    [No Abstract]   [Full Text] [Related]  

  • 34. The influence of drug ,reatment on norepinephrine levels and ultrastructure of the rat hypothalamus and caudate nucleus during a programmed light-dark cycle.
    Walker CA; Speciale SG; Friedman AH
    Neuropharmacology; 1971 May; 10(3):325-34. PubMed ID: 5090141
    [No Abstract]   [Full Text] [Related]  

  • 35. MODIFICATION BY DRUGS OF THE METABOLISM OF 3,4-DIHYDROXYPHENYLETHYLAMINE, NORADRENALINE AND 5-HYDROXYTRYPTAMINE IN THE BRAIN.
    LAVERTY R; SHARMAN DF
    Br J Pharmacol Chemother; 1965 Jun; 24(3):759-72. PubMed ID: 14340930
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of the d- and l-isomers of amphetamine on uptake, release and catabolism of norepinephrine, dopamine and 5-hydroxytryptamine in several regions of rat brain.
    Holmes JC; Rutledge CO
    Biochem Pharmacol; 1976 Feb; 25(4):447-51. PubMed ID: 938573
    [No Abstract]   [Full Text] [Related]  

  • 37. Amphetamine: differentiation by d and l isomers of behavior involving brain norepinephrine or dopamine.
    Taylor KM; Snyder SH
    Science; 1970 Jun; 168(3938):1487-9. PubMed ID: 5463064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modification by L-DOPA methylester (H 19-61) of amphetamine-induced brain catecholamine changes, thermal responses and toxicity in developing mice.
    Alhava E
    Acta Pharmacol Toxicol (Copenh); 1973; 33(5):330-47. PubMed ID: 4801079
    [No Abstract]   [Full Text] [Related]  

  • 39. Regional norepinephrine response to amphetamine using dialysis: comparison with caudate dopamine.
    Kuczenski R; Segal DS
    Synapse; 1992 Jun; 11(2):164-9. PubMed ID: 1626314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological studies on a possible role of central noradrenaline neurons in respiratory control.
    Bolme P; Fuxe K
    J Pharm Pharmacol; 1973 Apr; 25(4):351-2. PubMed ID: 4146697
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.